These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4364270)

  • 1. Cell-mediated immunity and blocking factors in patients with tumours of the central nervous system.
    Kumar S; Taylor G; Steward JK; Waghe MA; Morris-Jones P
    Int J Cancer; 1973 Jul; 12(1):194-205. PubMed ID: 4364270
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating immune complexes in human neuroblastoma: direct assay and role in blocking specific cellular immunity.
    Jose DG; Seshadri R
    Int J Cancer; 1974 Jun; 13(6):824-38. PubMed ID: 4136591
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific lymphocytotoxicity and blocking factors in tumours of the central nervous system.
    Kumar S; Taylor G
    Br J Cancer Suppl; 1973 Aug; 1():135-41. PubMed ID: 4804276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro demonstration of cell-mediated immunity to human brain tumors.
    Levy NL; Mahaley MS; Day ED
    Cancer Res; 1972 Mar; 32(3):477-82. PubMed ID: 4334410
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular immunity to human tumor-associated antigens. A review.
    Herberman RB
    Isr J Med Sci; 1973 Mar; 9(3):300-7. PubMed ID: 4575654
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular immunity in Wilm's tumour and neuroblastoma.
    Kumar S; Taylor G; Steward JK; Waghe MA; Pearson D
    Int J Cancer; 1972 Jul; 10(1):36-43. PubMed ID: 4350513
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular immunity against tumor-associated antigens in humans: lymphocyte stimulation and skin reaction.
    Vánky R; Klein E; Stjernswärd J; Nilsonne U
    Int J Cancer; 1974 Aug; 14(2):277-88. PubMed ID: 4376515
    [No Abstract]   [Full Text] [Related]  

  • 8. Human astrocytoma: serum-mediated immunologic response.
    Kornblith PL; Dohan FC; Wood WC; Whitman BO
    Cancer; 1974 Jun; 33(6):1512-9. PubMed ID: 4858205
    [No Abstract]   [Full Text] [Related]  

  • 9. Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors.
    Levy NL
    J Immunol; 1978 Sep; 121(3):903-15. PubMed ID: 211167
    [No Abstract]   [Full Text] [Related]  

  • 10. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.
    Brooks WH; Netsky MG; Normansell DE; Horwitz DA
    J Exp Med; 1972 Dec; 136(6):1631-47. PubMed ID: 4345108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Workshop in human tumor immunology.
    Oettgen HF; Bean MA; Klein G
    Cancer Res; 1972 Dec; 32(12):2845-53. PubMed ID: 4345410
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunochemical and immunological study of human brain tumors].
    Delpech B; Delpech A; Clément J; Laumonier R
    Int J Cancer; 1972 Mar; 9(2):374-82. PubMed ID: 4339413
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphocytic infiltration in gliomas: evidence of possible host resistance.
    Ridley A; Cavanagh JB
    Brain; 1971; 94(1):117-24. PubMed ID: 5552158
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell-mediated and humoral immune reactions to human tumours.
    Baldwin RW; Embleton MJ; Jones JS; Langman MJ
    Int J Cancer; 1973 Jul; 12(1):73-83. PubMed ID: 4790710
    [No Abstract]   [Full Text] [Related]  

  • 15. Relation between cellular immunity to nephroblastoma and the phase of the disease.
    Jereb B; Diehl V; Ahström L; Juhlin I
    Acta Paediatr Scand; 1972 Nov; 61(6):709-14. PubMed ID: 4342987
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of host immunity in human neoplasia. II. Discussion.
    Br J Cancer Suppl; 1973 Aug; 1():162-9. PubMed ID: 4374227
    [No Abstract]   [Full Text] [Related]  

  • 17. Poliovirus antibody response in patients with acute leukemia.
    Ogra PL; Sinks LF; Karzon DT
    J Pediatr; 1971 Sep; 79(3):444-9. PubMed ID: 4105452
    [No Abstract]   [Full Text] [Related]  

  • 18. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.
    Hellström I; Sjögren HO; Warner G; Hellström KE
    Int J Cancer; 1971 Mar; 7(2):226-37. PubMed ID: 5104167
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma.
    Heppner GH; Stolbach L; Byrne M; Cummings FJ; McDonough E; Calabresi P
    Int J Cancer; 1973 Mar; 11(2):245-60. PubMed ID: 4790694
    [No Abstract]   [Full Text] [Related]  

  • 20. [Demonstration of tumor-specific cellular immunity and blocking serum factors in children with neuro- and nephroblastoma using a new in-vitro test (Leukocyte adherence inhibition)].
    Lampert F; Dietmair E; Guggenberger K
    Monatsschr Kinderheilkd (1902); 1974 Jul; 122(7):648-9. PubMed ID: 4369532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.